Alt
/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_Consultant_Oncologist_Head_shot_GA_Mark_Tuthill.jpeg

Dr Mark Tuthill

Dr Mark Tuthill
Mark
Tuthill
MBBS BSc PhD FRCP, Consultant Medical Oncologist

Languages spoken

English and French

Expert in

Breast, prostate, kidney and bladder cancer

Centres

Oxford
Oxford

Peters Way, Sandy Lane West, Oxford, OX4 6LB

51.7239071200697, -1.2145938932540707
/uk/our-centres/oxford
+44 (0)1865 237 700
mediahawkNumber3680 mhMobile

Specialises in

Breast cancer
Condition
Condition/Cancer
Condition/Cancer/Breast cancer
Genitourinary cancer
Condition
Condition/Cancer
Condition/Cancer/Genitourinary cancer
Prostate cancer
Condition
Condition/Cancer
Condition/Cancer/Prostate cancer

Treatments

Radiotherapy
Service
Service/Cancer
Service/Cancer/Radiotherapy

Dr Mark Tuthill is a Consultant Medical Oncologist who specialises in the treatment of early and recurrent cancers of the breast, prostate, kidney and bladder. In 2015, he was appointed Consultant Medical Oncologist at Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, where, in addition, he acts as Chief and Principal investigator on a number of clinical trials.

Dr Tuthill focusses on providing a patient centred approach to treatment ensuring clear communication, evidence-based therapies and molecularly targeted therapies to enable personalised medicine. Treatments can include the use of chemotherapy, hormone therapy, immunotherapy, or cancer growth inhibitors and experimental treatments given as part of clinical trials.

Dr Tuthill originally qualified from University College London and trained in Medical Oncology in London. He holds a PhD in Tumour Immunology from Imperial College London and regularly presents his research at national and international conferences. Dr Tuthill is a clinical ambassador for UCARE (Urology Cancer Research and Education), an independent charity raising funds for research into prostate and bladder cancer and is a member of The Association of Cancer Physicians.

Dr Tuthill’s research interests include cancer vaccines, tumour immunology, cancer-growth inhibitors, and novel therapeutic drug combinations for the treatment of cancer. He is a Chief, principal investigator or sub-investigator for early and late phase clinical trials in tumour types including breast cancer, urological cancers and other tumour types.

Career positions

Current position(s)

  • The Churchill Hospital
  • Oxford University Hospitals NHS Foundation Trust

Education

Universities

  • University College London
  • PhD in Tumour Immunology from Imperial College London

Expertise and interests

Interests

  • Cancer vaccines, tumour immunology, cancer-growth inhibitors, and novel therapeutic drug combinations for the treatment of cancer. 

Accomplishments

Awards received

  • Clinical Excellence Award (2020)
  • Fellow of the Royal College of physicians (2019)
  • MRC Clinical Research training fellowship
  • Lady Cocket Scholarship c1635
  • British Society of Neuroradiology: Burrows Prize

Professional associations

Dr Mark Tuthill reviews